Clinical Trials Browser

Phase 3 × sodium thiosulfate × 90 days × Clear all

NCT05382338 2026-02-24

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Phase 3 Recruiting

Medulloblastoma